OP 7.2 – 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: four cases from the open label arm of the RIO trial

Autor: Lee, M., Collins, S., Kinloch, S., Fox, J., Seaton, K., Tomaras, G., Caskey, M., Nussenzweig, M., Frater, J., Fidle, S.

Publikováno v: In Journal of Virus Eradication December 2022 8 Supplement

Correction: The HIV Empowering Adults' Decisions to Share: UK/Uganda (HEADSUP) Study-A Randomised Feasibility Trial of an HIV Disclosure Intervention for Young Adults with Perinatally Acquired HIV.

Autor: Evangeli M; Department of Psychology, Royal Holloway University of London, Surrey TW20 0EX, Egham, UK. michael.evangeli@rhul.ac.uk., Gnan G; Department of Psychology, Royal Holloway University of London, Surrey TW20 0EX, Egham, UK., Musiime V; Makerere University, Kampala, Uganda.; Joint Clinical Research Centre, Kampala, Uganda., Fidle S; Department of Infectious Disease, Imperial College London, Imperial College NIHR BRC, London, UK., Seeley J; London School of Hygiene and Tropical Medicine, London, UK., Frize G; Central and North West London NHS Foundation Trust, London, UK.; Imperial College Healthcare NHS Trust, London, UK., Uwizera A; Joint Clinical Research Centre, Kampala, Uganda., Lisi M; Department of Psychology, Royal Holloway University of London, Surrey TW20 0EX, Egham, UK., Foster C; Imperial College Healthcare NHS Trust, London, UK.

Publikováno v: AIDS and behavior [AIDS Behav] 2024 Jun; Vol. 28 (6), pp. 1965.